Baidu
map

Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis

Vong, C; Martin, SW; Deng, CH; Xie, RJ; Ito, K; Su, CY; Sandborn, WJ; Mukherjee, A

Mukherjee, A (corresponding author), Pfizer Inc, 558 Eastern Point Rd, Groton, CT 06340 USA.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021; 10 (3): 229

Abstract

Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We characterized tofacitinib pharmacokinet......

Full Text Link


Baidu
map
Baidu
map
Baidu
map